About
Welsh, Carson, Anderson & Stowe (WCAS) was founded in 1979 and has established itself as a leading U.S. private equity firm with an exclusive focus on two sectors: technology and healthcare. Based in New York, the firm operates with a deal-size agnostic investment strategy, targeting growth-oriented companies primarily across the United States. Since inception, WCAS has organized over 30 limited partnerships with total capital commitments exceeding $40 billion, demonstrating sustained institutional backing and consistent fundraising capability. The firm's most recent fund raised over $5 billion, marking its largest vehicle to date. As of early 2026, WCAS maintains an active portfolio of 109 companies accumulated through 74 funding rounds and 41 acquisitions, reflecting a diversified approach to value creation. The investment thesis centers on deep partnership with exceptional management teams, combining operational improvements with strategic acquisition opportunities to build enterprise value. WCAS's healthcare investments have included established platforms such as Concentra, while its technology portfolio spans business and productivity software applications serving various end markets including government and healthcare services. The firm's limited partners have historically included institutional investors such as the California State Teachers' Retirement System, the Minnesota State Board of Investment, and the Board of Education Retirement System of the City of New York, indicating appeal to sophisticated public pension capital. Portfolio companies benefit from the firm's sector expertise, operational resources, and network effects built over four decades of consistent investing in these two verticals. Investors in WCAS funds gain exposure to carefully selected mid-market to large-cap companies with established revenue bases and operational scalability, supported by a disciplined value creation framework refined through multiple market cycles.